Mendelian Randomization Study Reveals Causal Pathways for Hypertrophic Cardiomyopathy, Cardiovascular Proteins, and

Yifei Zhang1, Chenyuan Guo1, Lanxin Wang1

  • 1The Cardiology Department of Shanxi Provincial People's Hospital, Shanxi Medical University, Taiyuan, Shanxi, China.

Insights

Hypertrophic cardiomyopathy (HCM) may increase the risk of developing atrial fibrillation (AF). Melusin protein acts as a protective mediator in this cardiovascular disease relationship.

Area of Science:

  • Cardiology
  • Genetics
  • Epidemiology

Background:

  • A significant association exists between hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF).
  • The causal relationship and underlying mechanisms between HCM and AF require further investigation.
  • Cardiovascular proteins (CPs) may play a role in the interplay between HCM and AF.

Purpose of the Study:

  • To investigate the causal relationship between hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF) using Mendelian randomization (MR).
  • To assess the mediating role of cardiovascular proteins (CPs) in the association between HCM and AF through a two-step MR analysis.

Main Methods:

  • Employed a two-sample and bidirectional Mendelian randomization (MR) approach.
  • Utilized data from FinnGen and IEU Open GWAS Project for HCM, AF, and 90 CPs.
  • Applied MR-Egger, inverse variance weighting (IVW), and weighted median estimator (WME) for causal inference, alongside mediation analysis for CPs.

Main Results:

  • Bidirectional MR indicated HCM as a risk factor for AF (OR=1.008, p=0.029).
  • Five CPs were causally linked to HCM, 12 to AF, and Melusin to both.
  • Melusin demonstrated a protective effect and acted as a mediator between HCM and AF (mediation ratio 5.5178%).

Conclusions:

  • Hypertrophic cardiomyopathy (HCM) may elevate the risk of developing atrial fibrillation (AF).
  • Melusin protein is identified as a potential mediator in the causal pathway between HCM and AF.
  • These findings contribute to understanding the complex relationship between these cardiovascular conditions.